BD Phoenix® 自动微生物学系统 - GN 奈替米星(0.0156-4 µg/mL)
K号: K233986 · 2024-03-15
广告
器械摘要
常见问题
What is the BD Phoenix™ Automated Microbiology System - GN Ciprofloxacin (0.0156–4 µg/mL)?
BD Phoenix™ Automated Microbiology System - GN Ciprofloxacin (0.0156–4 µg/mL) is a medical device that received FDA 510(k) clearance on 2024-03-15. The listed applicant is Becton, Dickinson and Company. The 510(k) number is K233986.
When did BD Phoenix™ Automated Microbiology System - GN Ciprofloxacin (0.0156–4 µg/mL) receive FDA 510(k) clearance?
BD Phoenix™ Automated Microbiology System - GN Ciprofloxacin (0.0156–4 µg/mL) received FDA 510(k) clearance on 2024-03-15, under 510(k) number K233986.
Who is the listed applicant for BD Phoenix™ Automated Microbiology System - GN Ciprofloxacin (0.0156–4 µg/mL)?
The FDA 510(k) record lists Becton, Dickinson and Company as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for BD Phoenix™ Automated Microbiology System - GN Ciprofloxacin (0.0156–4 µg/mL)?
The FDA product code for BD Phoenix™ Automated Microbiology System - GN Ciprofloxacin (0.0156–4 µg/mL) is LON.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
列明Becton, Dickinson and Company为申报人的其他记录
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
相关器械(代码:LON)
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。
广告